Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 4
2(40.0%)
5Total
N/A(3)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06457698Not ApplicableActive Not Recruiting

Temporomandibular Bioviscosuplementation (Platelet-Rich Plasma Combined With Hyaluronic Acid) After Double-Puncture Arthrocentesis: a Randomized Controlled Trial

Role: lead

NCT05817162Phase 4Unknown

Temporomandibular Joint Arthrocentesis With Infiltration of PRP + Ropivacaine Versus PRP

Role: lead

NCT04810429Phase 4Completed

Comparison of Temporomandibular Joint Arthroscopy With Botulinum Toxin Injection Versus Placebo

Role: lead

NCT05027243Not ApplicableCompleted

Outcomes of Bilateral Temporomandibular Joint Arthroscopy and the Role of a Second Intervention - Timings and Results

Role: lead

NCT04857294Not ApplicableCompleted

Unilateral TMJ Discectomy Without Interposal Material in Patients With Disc Perforation or Fragmentation

Role: lead

All 5 trials loaded